ELISA APOC3 anti-

Quantity :50µL Clone Number:8H12 Aliases:Apolipoprotein C-III (Apo-CIII) (ApoC-III) (Apolipoprotein C3), APOC3 Product Type:Recombinant Antibody Immunogen Species:Homo sapiens () UniProt ID:P02656 Immunogen:A syntheQuantityd peptide derived from APOC3 Raised in: Reactivity: Tested Applications:ELISA, IHC; Recommended dilution: IHC:1:50-1:200 Background:Component of triglyceride-rich very low density lipoproteins (VLDL) and high density lipoproteins (HDL) in plasma (PubMed:18201179, PubMed:22510806). Plays a mµLtifaceted role in triglyceride homeostasis (PubMed:18201179, PubMed:22510806). IntracellµLarly, promotes hepatic very low density lipoprotein 1 (VLDL1) assembly and secretion; extracellµLarly, attenuates hydrolysis and clearance of triglyceride-rich lipoproteins (TRLs) (PubMed:18201179, PubMed:22510806). Impairs the lipolysis of TRLs by inhibiting lipoprotein lipase and the hepatic uptake of TRLs by remnant receptors (PubMed:18201179, PubMed:22510806). Formed of several curved helices connected via semiflexible hinges, so that it can wrap tightly around the curved micelle surface and easily adapt to the different diameters of its natural binding partners (PubMed:18408013). Clonality:Monoclonal Isotype:Rabbit IgG Purification Method:Affinity-chromatography Conjµgate:Non-conjµgated Buffer:Rabbit IgG in phosphate buffered saline, pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol. Form:Liquid Stroage:Upon receipt, store at -20°C or -80°C. Avoid repeated freeze. Target Names:APOC3 Research Areas:Cancer; CardiovascµLar; Metabolism; Signal transduction